Citadel Advisors’s IO Biotech IOBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.1K Sell
28,866
-16,689
-37% -$23.2K ﹤0.01% 5524
2025
Q1
$49.7K Sell
45,555
-224,949
-83% -$245K ﹤0.01% 5360
2024
Q4
$249K Buy
+270,504
New +$249K ﹤0.01% 4690
2024
Q3
Sell
-86,894
Closed -$102K 6223
2024
Q2
$102K Buy
86,894
+28,272
+48% +$33.1K ﹤0.01% 4945
2024
Q1
$103K Buy
58,622
+6,755
+13% +$11.8K ﹤0.01% 5073
2023
Q4
$97.5K Buy
+51,867
New +$97.5K ﹤0.01% 4882
2023
Q3
Sell
-37,690
Closed -$73.9K 6169
2023
Q2
$73.9K Sell
37,690
-9,152
-20% -$17.9K ﹤0.01% 4860
2023
Q1
$87.6K Buy
+46,842
New +$87.6K ﹤0.01% 4959
2022
Q4
Sell
-42,180
Closed -$114K 6377
2022
Q3
$114K Buy
42,180
+27,754
+192% +$75K ﹤0.01% 5065
2022
Q2
$67K Buy
+14,426
New +$67K ﹤0.01% 5424
2022
Q1
Sell
-13,060
Closed -$86K 6729
2021
Q4
$86K Buy
+13,060
New +$86K ﹤0.01% 5976